関連する実験動画
Updated: Feb 13, 2026
08:41
Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
9.6K
状態制約とパラメータ感受性分析を備えた非線形化学療法モデルの薬物スケジュールの最適制御
Emad Abdullah Musleh1, Jeevan Kanesan1, Joon Huang Chuah1
1Department of Electrical Engineering, Faculty of Engineering, University of Malaya, Kuala Lumpur, Malaysia.
Computer methods in biomechanics and biomedical engineering
|February 12, 2026
まとめ
この研究は,腫瘍のサイズを32.8%減らすための最適なコントロールを使用して,がん化学療法スケジュールを最適化しています. このアプローチは,適応的スケジューリングのための腫瘍と薬物のパラメータを考慮することによって,個別化された治療を強化します.
科学分野:
- * 数学的な腫瘍学
- * コンピュータ生物学
- * バイオメディカルエンジニアリング
背景:
- *がん化学療法スケジューリングは複雑で,腫瘍減少と毒性および薬理学的な制約のバランスをとります.
- * 非線形数学モデルは,腫瘍の動態と薬物の効果をシミュレートする上で極めて重要です.
- * 最適制御理論は,治療戦略の最適化のための枠組みを提供します.
研究 の 目的:
- *がん化学療法のためのバングバングの最適なコントロールフレームワークを開発し,適用する.
- * 毒性の限界を含む州制約を尊重しながら,腫瘍の負担を最小限に抑える.
- * パラメータの感受性を調査し,適応的で患者特有の治療スケジュールを設定できるようにする.
主な方法:
- * 状態の制約を持つ非線形がん化学療法モデルが策定されました.
- * 薬物動力学的パラメータと累積毒性の限界が組み込まれました.
- *IPOPTによるAMPLにおける高解像度ディスクリタイゼーションアプローチは,数値解答に使用されました.
主要な成果:
- * 最終的な腫瘍サイズは9.9466 × 10^3で,以前の方法と比較して32.8%の改善を達成しました.
- * 時間に依存する腫瘍減少の制約を調査し,重要な生物学的パラメータに対する感受性分析を行った.
- * フレームワークの適応的かつ個別化された化学療法スケジュールの可能性を実証しました.
結論:
- * 提案された最適制御の枠組みは,適応的,患者特有の化学療法のための基礎を提供します.
- * パラメータ感度分析の統合により,治療のパーソナライゼーションが強化されます.
- *臨床翻訳には,実際の患者データによるさらなる検証が必要である.
関連する概念動画
01:13Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model
322
Drugs administered through various routes can lead to nonlinear elimination, resulting in complex pharmacokinetic behaviors crucial to understanding efficacious drug dosing.
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
322
01:25Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview
369
Drug administration can occur through various routes, each of which may result in a different process of elimination. This process is often mixed with nonlinear and linear processes. It's important to understand that a single drug can be metabolized into different metabolites through parallel processes.
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
369
01:24Reinforcement Schedules
527
Positive reinforcement is a powerful method for teaching new behaviors to both animals and humans. B.F. Skinner demonstrated this with his experiments using rats in a Skinner box. When a rat pressed a lever, it received a food pellet. This immediate reward encouraged the rat to repeat the behavior. This method, where a reward follows every instance of the behavior, is known as continuous reinforcement. It is highly effective for establishing new behaviors quickly.
Once a behavior is learned,...
Once a behavior is learned,...
527
01:22Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
631
When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
631
01:22Nonlinear Pharmacokinetics: Causes of Nonlinearity
745
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
745
00:59Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
429
In pharmacokinetics, the elimination rate of a drug following a capacity-limited model is primarily controlled by two parameters: Vmax and KM. These parameters are crucial in how the drug behaves inside the body after administration.
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
429